IDSA on X: New in CID: A #dengue vaccine candidate was efficacious against symptomatic dengue in children and adolescents over 3 years post-vaccination across 8 endemic countries. 📄: #IDSAJournals #ClinInfectDis

The Impact of the Newly Licensed Dengue Vaccine in Endemic

Impact of preexisting dengue immunity on Zika virus emergence in a

Is new dengue vaccine efficacy data a relief or cause for concern

Dengue Vaccine: Recommendations of the Advisory Committee on

Invasive Pneumococcal Disease in Children 5 Years After Conjugate

Vaccine Eligibility & Recommendations, Dengue

Immunogenicity and safety of booster CYD-TDV dengue vaccine after

Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and

Invasive Haemophilus influenzae Type B Disease in Five

Is new dengue vaccine efficacy data a relief or cause for concern

Invasive Pneumococcal Disease in Children 5 Years After Conjugate

Resources, Dengue

Current Status of Vaccines against Dengue Virus